Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments.

Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments. Abstract Text:

Depression during pregnancy and in the postpartum period is common, devastating to mothers and their offspring, and poorly understood in terms of pathophysiology. In this issue of Neuron, Maguire and Mody provide evidence for a role for aberrant neurosteroid regulation of the GABA(A) receptor subunit in the etiology of postpartum depression, presaging elucidation of the pathophysiology and development of treatments of this depression endophenotype.

Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Neuron

VOLUME: 59

Page Numbers: 185-6

Journal Abbreviation: Neuron

ISSN: 1097-4199

DAY: 31

MONTH: Jul

YEAR: 2008

Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8809320

Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments.

AFFILIATION: Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA. cnemero@emory.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neuron

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments Related Publications

• An interactive web-based method of outreach to college students at risk for suicide.
• CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia.
• Cuba II: A Land Stuck in Time.
• Cuba: a land stuck in time.
• Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy.
• Depression and endocrine disorders: focus on the thyroid and adrenal system.
• Depression, desperation, and suicidal ideation in college students: results from the American Foundation for Suicide Prevention College Screening Project at Emory University.
• Drug development for anxiety disorders: new roles for atypical antipsychotics.
• Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders.
• Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.
• Emerging treatments for depression.
• Endogenous neurotensin is involved in estrous cycle related alterations in prepulse inhibition of the acoustic startle reflex in female rats.
• Fostering foster care outcomes: quality of intervention matters in overcoming early adversity.
• How are you?
• Involvement of neuropeptide systems in schizophrenia: human studies.
• Neuropeptides and Alzheimer's disease.
• Neurotensin: role in psychiatric and neurological diseases.
• New directions in the development of antidepressants: the interface of neurobiology and psychiatry.
• One brain, but different clinical disciplines: should psychiatry and neurology be United?
• Overview of the safety of citalopram.
• Sertraline and desmethylsertraline in human breast milk and nursing infants.
• Stress, menopause and vulnerability for psychiatric illness.
• The burden of severe depression: a review of diagnostic challenges and treatment alternatives.
• The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma.
• The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression.
• The neurobiology of bipolar disorder.
• The neurobiology of social anxiety disorder: the relevance of fear and anxiety.
• The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations.
• The role of patient advocacy in funding policy.
• Understanding the pathophysiology of postpartum depression: implications for the development of novel treatments.